Body burden and health risk of pharmaceuticals in elderly population: A multi-site biomonitoring study in China

Evidence suggests that pharmaceuticals (PhACs) are widespread in the environment and may pose a threat to human health. However, limited health risk assessments are available for PhAC exposure in large and multi-site populations, especially among vulnerable populations. To address this gap, we condu...

Full description

Saved in:
Bibliographic Details
Main Authors: Fangting Hu, Yi Liu, Xiaoting Liu, Sheng Wang, Liang Ruan, Xuechun Liu, Qi Zhong, Xinsheng Qin, Panzhu Qin, Hanyu Xuan, Fangbiao Tao, Kaiyong Liu
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Ecotoxicology and Environmental Safety
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0147651325008085
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849694460935405568
author Fangting Hu
Yi Liu
Xiaoting Liu
Sheng Wang
Liang Ruan
Xuechun Liu
Qi Zhong
Xinsheng Qin
Panzhu Qin
Hanyu Xuan
Fangbiao Tao
Kaiyong Liu
author_facet Fangting Hu
Yi Liu
Xiaoting Liu
Sheng Wang
Liang Ruan
Xuechun Liu
Qi Zhong
Xinsheng Qin
Panzhu Qin
Hanyu Xuan
Fangbiao Tao
Kaiyong Liu
author_sort Fangting Hu
collection DOAJ
description Evidence suggests that pharmaceuticals (PhACs) are widespread in the environment and may pose a threat to human health. However, limited health risk assessments are available for PhAC exposure in large and multi-site populations, especially among vulnerable populations. To address this gap, we conducted biomonitoring of 46 representative PhACs in urine samples from 3096 older adults. PhAC concentrations, adjusted for urine specific gravity, were used to calculate the estimated daily intake (EDI) and assess associated health risks. All individuals had at least one PhAC detected in their urine, with the detection rates of sulfameter, acetaminophen, metformin, and sulfamonomethoxine exceeding 70 %. Median PhAC concentrations ranged from below the limit of detection to 29.79 ng/mL. The EDI values were generally low, with the exception of those of nine PhACs, whose EDI values exceeded 1000 µg/kg/day at the 99th percentile. Total antibiotic exposure posed a health risk in 13.9 % of all individuals. Amoxicillin, florfenicol, and ciprofloxacin were major contributors to the potential health risk of gut microbiota disruption. Among the non-antibiotic PhACs, acetaminophen, amantadine, and metformin posed potential health risks to 2.2 %, 1.9 %, and 0.9 % of all individuals, respectively. Overall, this study sheds light on PhAC exposure in older adults across different regions and provides valuable insights that can help with safeguarding their health.
format Article
id doaj-art-4afefa37cfea408393cc7cacb411f211
institution DOAJ
issn 0147-6513
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Ecotoxicology and Environmental Safety
spelling doaj-art-4afefa37cfea408393cc7cacb411f2112025-08-20T03:20:04ZengElsevierEcotoxicology and Environmental Safety0147-65132025-07-0130011846810.1016/j.ecoenv.2025.118468Body burden and health risk of pharmaceuticals in elderly population: A multi-site biomonitoring study in ChinaFangting Hu0Yi Liu1Xiaoting Liu2Sheng Wang3Liang Ruan4Xuechun Liu5Qi Zhong6Xinsheng Qin7Panzhu Qin8Hanyu Xuan9Fangbiao Tao10Kaiyong Liu11School of Public Health, Anhui Medical University/Center for Big Data and Population Health, Institute of Health and Medicine, Hefei Comprehensive National Science Center, No 81 Meishan Road, Hefei, Anhui 230032, China; Key Laboratory of Population Health Across Life Cycle (Anhui Medical University),Ministry of Education of the People’s Republic of China, No 81 Meishan Road, Hefei, Anhui 230032, China; Anhui Provincial Key Laboratory of Environment and Population Health Across the Life Course/Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui 230032, ChinaSchool of Public Health, Anhui Medical University/Center for Big Data and Population Health, Institute of Health and Medicine, Hefei Comprehensive National Science Center, No 81 Meishan Road, Hefei, Anhui 230032, ChinaSchool of Public Health, Anhui Medical University/Center for Big Data and Population Health, Institute of Health and Medicine, Hefei Comprehensive National Science Center, No 81 Meishan Road, Hefei, Anhui 230032, ChinaCenter for Scientific Research, Anhui Medical University, Hefei, Anhui 230032, ChinaSchool of Public Health, Anhui Medical University/Center for Big Data and Population Health, Institute of Health and Medicine, Hefei Comprehensive National Science Center, No 81 Meishan Road, Hefei, Anhui 230032, ChinaHefei Hospital affiliated to Anhui Medical University (Hefei Second People’s Hospital), Hefei, Anhui 230011, ChinaSchool of Public Health, Anhui Medical University/Center for Big Data and Population Health, Institute of Health and Medicine, Hefei Comprehensive National Science Center, No 81 Meishan Road, Hefei, Anhui 230032, ChinaSchool of Public Health, Anhui Medical University/Center for Big Data and Population Health, Institute of Health and Medicine, Hefei Comprehensive National Science Center, No 81 Meishan Road, Hefei, Anhui 230032, ChinaSchool of Public Health, Anhui Medical University/Center for Big Data and Population Health, Institute of Health and Medicine, Hefei Comprehensive National Science Center, No 81 Meishan Road, Hefei, Anhui 230032, ChinaSchool of Big Data and Statistics, Anhui University, Hefei, Anhui 230601, ChinaSchool of Public Health, Anhui Medical University/Center for Big Data and Population Health, Institute of Health and Medicine, Hefei Comprehensive National Science Center, No 81 Meishan Road, Hefei, Anhui 230032, China; Key Laboratory of Population Health Across Life Cycle (Anhui Medical University),Ministry of Education of the People’s Republic of China, No 81 Meishan Road, Hefei, Anhui 230032, China; Anhui Provincial Key Laboratory of Environment and Population Health Across the Life Course/Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui 230032, ChinaSchool of Public Health, Anhui Medical University/Center for Big Data and Population Health, Institute of Health and Medicine, Hefei Comprehensive National Science Center, No 81 Meishan Road, Hefei, Anhui 230032, China; Key Laboratory of Population Health Across Life Cycle (Anhui Medical University),Ministry of Education of the People’s Republic of China, No 81 Meishan Road, Hefei, Anhui 230032, China; Anhui Provincial Key Laboratory of Environment and Population Health Across the Life Course/Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui 230032, China; Correspondence to: School of Public Health, Anhui Medical University, No. 81 Meishan Road, Hefei, Anhui 230032, China.Evidence suggests that pharmaceuticals (PhACs) are widespread in the environment and may pose a threat to human health. However, limited health risk assessments are available for PhAC exposure in large and multi-site populations, especially among vulnerable populations. To address this gap, we conducted biomonitoring of 46 representative PhACs in urine samples from 3096 older adults. PhAC concentrations, adjusted for urine specific gravity, were used to calculate the estimated daily intake (EDI) and assess associated health risks. All individuals had at least one PhAC detected in their urine, with the detection rates of sulfameter, acetaminophen, metformin, and sulfamonomethoxine exceeding 70 %. Median PhAC concentrations ranged from below the limit of detection to 29.79 ng/mL. The EDI values were generally low, with the exception of those of nine PhACs, whose EDI values exceeded 1000 µg/kg/day at the 99th percentile. Total antibiotic exposure posed a health risk in 13.9 % of all individuals. Amoxicillin, florfenicol, and ciprofloxacin were major contributors to the potential health risk of gut microbiota disruption. Among the non-antibiotic PhACs, acetaminophen, amantadine, and metformin posed potential health risks to 2.2 %, 1.9 %, and 0.9 % of all individuals, respectively. Overall, this study sheds light on PhAC exposure in older adults across different regions and provides valuable insights that can help with safeguarding their health.http://www.sciencedirect.com/science/article/pii/S0147651325008085PharmaceuticalsElderlyHuman biomonitoringHealth risk assessment
spellingShingle Fangting Hu
Yi Liu
Xiaoting Liu
Sheng Wang
Liang Ruan
Xuechun Liu
Qi Zhong
Xinsheng Qin
Panzhu Qin
Hanyu Xuan
Fangbiao Tao
Kaiyong Liu
Body burden and health risk of pharmaceuticals in elderly population: A multi-site biomonitoring study in China
Ecotoxicology and Environmental Safety
Pharmaceuticals
Elderly
Human biomonitoring
Health risk assessment
title Body burden and health risk of pharmaceuticals in elderly population: A multi-site biomonitoring study in China
title_full Body burden and health risk of pharmaceuticals in elderly population: A multi-site biomonitoring study in China
title_fullStr Body burden and health risk of pharmaceuticals in elderly population: A multi-site biomonitoring study in China
title_full_unstemmed Body burden and health risk of pharmaceuticals in elderly population: A multi-site biomonitoring study in China
title_short Body burden and health risk of pharmaceuticals in elderly population: A multi-site biomonitoring study in China
title_sort body burden and health risk of pharmaceuticals in elderly population a multi site biomonitoring study in china
topic Pharmaceuticals
Elderly
Human biomonitoring
Health risk assessment
url http://www.sciencedirect.com/science/article/pii/S0147651325008085
work_keys_str_mv AT fangtinghu bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT yiliu bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT xiaotingliu bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT shengwang bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT liangruan bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT xuechunliu bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT qizhong bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT xinshengqin bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT panzhuqin bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT hanyuxuan bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT fangbiaotao bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina
AT kaiyongliu bodyburdenandhealthriskofpharmaceuticalsinelderlypopulationamultisitebiomonitoringstudyinchina